Provided by Tiger Trade Technology Pte. Ltd.

PDS Biotechnology Corporation

0.3047
+0.01173.99%
Volume:6.31M
Turnover:1.93M
Market Cap:17.01M
PE:-0.48
High:0.3300
Open:0.2900
Low:0.2850
Close:0.2930
52wk High:1.55
52wk Low:0.1952
Shares:55.82M
Float Shares:54.40M
Volume Ratio:0.21
T/O Rate:11.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6401
EPS(LYR):-0.7437
ROE:-543.97%
ROA:-70.59%
PB:-4.75
PE(LYR):-0.41

Loading ...

PDS Biotechnology Price Target Cut to $5.00/Share from $7.00 by HC Wainwright & Co.

Dow Jones
·
Yesterday

PDS Biotechnology Corporation : H.c. Wainwright Cuts Target Price to $5 from $7

THOMSON REUTERS
·
Yesterday

PDS Biotechnology Raises $22.6 Million in Equity Funding; Shares Rise

MT Newswires Live
·
Sep 08

PDS Biotech Adds NantWorks Founder Patrick Soon-Shiong to Board Under PIPE Deal

Reuters
·
Sep 08

PDS Biotech Prices up to USD 22.55 Million PIPE Led by Nant Capital

Reuters
·
Sep 08

PDS Biotech Announces up to $22.55 Million Financing Led by DR. Patrick Soon-Shiong, Founder of Nantworks

THOMSON REUTERS
·
Sep 08

PDS Biotech Amends USD 6 Million Promissory Note with YA II PN Ltd

Reuters
·
Sep 05

PDS Biotech Removes COO Stephan Toutain Without Cause

Reuters
·
Aug 26

PDS Biotechnology Corp - on Aug 6, Approved Reduction in Force to Align Expenses with Strategic Priorities - SEC Filing

THOMSON REUTERS
·
Aug 26

PDS Biotechnology Corp - Stephan Toutain Removed as Chief Operating Officer Effective August 21, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 26

PDS Biotechnology Says Lars Boesgaard to Resign as CFO Effective September 12

Reuters
·
Aug 20

PDS Biotechnology - Lars Boesgaard to Resign as CFO, Principal Financial Officer & Principal Accounting Officer Effective Sept 12- SEC Filing

THOMSON REUTERS
·
Aug 20

PDS Biotech Names Controller Janetta Trochimiuk Interim Principal Accounting Officer as CFO Resigns

Reuters
·
Aug 20

PDS Biotech Holds Annual Shareholder Meeting, Quorum Reached

Reuters
·
Aug 14

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 13

PDS Biotechnology Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

PDS Biotechnology Q2 Net Loss Widens Slightly as Operating Costs Fall

Reuters
·
Aug 13

PDS Biotech Q2 FY26 Net Loss Widens to $9.8 Million; R&D Expense Falls 22.49% to $3.3 Million

Reuters
·
Aug 13

PDS Biotech Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 13

PDS Biotechnology Q2 EPS USD -0.18

THOMSON REUTERS
·
Aug 13